Dow Jones 13442.52 +17.64 7:43 am PDT, September 16, 2007 NASDAQ 2602.18 +0.00 For info, visit access.smallcapnetwork.com S & P 500 1484.25 +0.30 Change your subscription status here Russell 2000 783.49 +0.00 VOLUME 07 : ISSUE 86 Time Isn't Money: A No-Risk, High Potential Investment  I know I've been talking about a new small cap trading idea for a few weeks now. After I tell you what I can about it today, I think you'll understand why I'm so excited. But first, just chew on these stock returns for a moment...135% in a year and half, 1614% in 16 years, and 14,983% (yes, five digits) over a span of 37 years. With numbers like that, I'd swear we were talking about a software or computer technology company that had managed to capitalize on some sort of industry breakthrough.  The truth is, however, these numbers didn't come from technology stocks - they came from restaurant stocks. Respectively, those were the percentage returns from Chipotle Mexican Grill (NYSE: CMG), IHOP Corporation (NYSE: IHP), and McDonald's (NYSE: MCD).  Surprised to learn a restaurant can produce those kinds of numbers? Some people might be, while others won't be. All I can say is, growth is growth. If I have chance to out up those kinds of numbers by jumping into the right stock at the right time, frankly, I don't care what they do. And yes, we believe this restaurant stock we're planning on covering soon could be just as capable of putting up those same kind of numbers. You know what though? Before you invest one red cent in the company, I'm going to recommend you first invest something that's completely free - just a little of your time. Is that a deal or what? It's a no-risk investment that, if you do decide to become an owner, could end up making you thousands of dollars.  As of right now, we plan on unveiling the stock on the 21st - this coming Friday. I think you owe it to yourself to invest a little time on Friday to get to know this fast-growing company through a short web-video and some more details from us. Why? If you like what you see (and I think you will), you can then choose to take the next step.  Personally, I've been blown away by what I've seen so far, and I have to believe this is going to be something the market will get excited about in the proverbial blink of an eye. Ergo, I feel 'sooner' will be better than 'later' when it comes to becoming an owner. But I digress...    State of the Industry  The restaurant industry is probably one of the most dynamic fields I can imagine. Consumer's tastes are constantly changing, yet those same consumers clamor for consistency. Sometimes they're price-conscious, and other times, they're health-conscious. In my observation, the organizations able to find a way to balance all of those decision-making factors are the ones who end up with customers coming in droves.  At the same time, being in the right environment/market at the right time can make a world of difference too. Did you know the National Restaurant Association thinks the 'quick & casual' segment of the restaurant biz is going to hit double-digit growth in 2007? This industry already generates more than $500 billion (yes, with a 'b') in sales each year in the United States, so we're talking about some major growth of already-big numbers.  And on a macro scale, you don't need me to tell you this nation is becoming more and more concerned about how healthy they eat. Organic food sales are up, bottled water sales are up, carbs and calories are now being listed on the menus next to each entree, while anything fried is a liability.  So what? The way I see it, this restaurant is hitting all those nails right on the head. It's a quick and casual venue, prices are reasonable with plenty of room for good margins, and there are no greasy hunks of meat involved. More than any of that though, the food's great too. (It's all moot unless the food's good, right?) In other words, it's the kind of eatery that can draw a crowd and keep 'em coming back. That's got to be good for sales and earnings...and shareholders.  Bottom line: There's a reason this relatively young company is also one of the fastest-growing restaurant chains in the country.    Next Step  Here's where I'd normally start listing all the specific reasons why I think you'd want to be a shareholder in one of our ideas. Today, though, I'm not even going to go down that path today. Why not? Because like I said, this Friday, the Small Cap Network has something a little different for our readers. We've got a video from the company, to which we'll be adding another layer of detail. The brief film will speak for itself about the investment potential we're eying.  OK, I probably said too much already, but trust me - you're going to want to keep an eye out for Friday's newsletter when we launch our coverage. I think this company could pay-off big for early investors who realize just how many things this company is already doing right. All the proverbial planets seem to be lining up. I really feel we could be looking at the next Chipotle, or even McDonald's-caliber growth. See you Friday.      We Value Your Feedback   Got comments, questions or suggestions? Send 'em on over: Email the Editor If you wish to send a written request or inquiry, please send it to our physical address: TGR Group, LLC 4653 Carmel Mtn Rd Suite 308 #402 San Diego, CA 92130 CEL-SCI (CVM) Sends Shareholder Letter - Highlights Cancer Therapy Progress  We finally got an update from CEL-SCI Corporation (AMEX: CVM) about its cancer therapy drug Multikine. The update came in the form of a letter to shareholders from CEO Geert Kersten, and serves as a nice recap of how they intend to develop a biotechnology known as immunotherapy and turn it into a one-of-a-kind treatment for head and neck cancer. Though scientific in nature, the letter looks at their work-to-date through the eyes of a biotech stock investor. If you've been along for the CEL-SCI ride since the beginning - and have kept up with our coverage - we don't think you'll find anything new in the letter. But, if you're not familiar with what the company is doing and want a full explanation of why this stock could make for a good longer-term biotech investment, it may do you some good to read it. Just click here. The premise and promise behind the biotechnology are pretty amazing.    BioCurex (BOCX) Shares at New Multi-Week Highs  Like I said a few days ago (and a few days before that), it looks like something is going on with BioCurex (OTCBB: BOCX). Shares of this small-cap biotech was up by more than 20% on Friday...up to its highest levels in weeks. Volume is through the roof. And yet, no news? Based on what we know about this small company and its cancer test research, I'm more and more convinced something big is on the way.  I wish I had something more concrete to say, but I don't. I just know the 80/20 rule applies to trading as well...80% of stock's gains are made during 20% of their life. Personally, I think we're entering one of those 20% scenarios. Where or how it will all come out is still anybody's guess. But, I've seen $1.32 act as resistance on the more recent side of the chart. A move past that could spark a rally to $2.00.  Be prepared for volatility (i.e. stay nimble), but I like our chances here.  Subscribe Information is power and timely information is profitable. Become informed and profit from Small Cap Network Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the Small Cap Network Email Newsletter on a regular basis. To ensure newsletter delivery, you can add any additional email addresses you may have to the Small Cap Network Member List. Receiving the Small Cap Network Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the Small Cap Network recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery. Subscribe Here Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the Small Cap Network Newsletter, simply follow the instructions located at the bottom of every Small Cap Network Newsletter Edition. Unsubscribe Here D I S C L A I M E R: The Small Cap Network, its website and email newsletter (hereafter, cumulatively referred to as "SCN") , is an independent electronic publication committed to providing its readers with factual information on select publicly traded companies. SCN is owned and operated by TGR Group, LLC ("TGR"). All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. Moreover, as detailed below, TGR accepts compensation from third party consultants and/or companies, which it features in the publication and circulation of SCN. To the degrees enumerated herein, SCN should not be regarded as an independent publication.  Click Here or go to http://access.smallcapnetwork.com/compensation_disclosure.html to view our compensation on every company we have ever covered, or visit the following web address: http://access.smallcapnetwork.com/profile_disclosure.html for our full profiles and http://access.smallcapnetwork.com/short_term_alerts.html for Trading Alerts.  TGR Group LLC has been paid a fee of $30,000 cash by Titan General for coverage of the company. In addition, TGR Group LLC has been pledged a fee of 100,000 warrants convertible at $1 into restricted shares by Trilogy Capital for coverage of the company.  In October of 2003, TGR Group LLC was paid a fee of $25,000 and one million newly issued restricted shares by Biocurex for coverage of the Company. Under SEC Rule 144, all one million issued restricted shares have been eligible for sale into the public market since October of 2004. In addition, on March 22, 2005, TGR entered into an extended agreement with Biocurex for a fee of 25,000 newly issued restricted shares and on July 1, 2006 TGR entered into another extended agreement with Biocurex for an additional 100,000 shares of newly issued, restricted stock. From time to time TGR sells shares received as compensation for coverage of client companies. Shares received are sold in the open market. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, TGR does not view the sale of the shares as contradictory to any opinions delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.  TGR, its Members and Members' families, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed.  All statements and expressions are the sole opinions of TGR and are subject to change without notice. A profile, description, or other mention of a company within SCN is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.  The profiles, critiques, and other editorial content of SCN may contain statements that appear foward relating to the expected capabilities of the companies mentioned herein.  THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF TGR.  We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.gov and/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.